Aptevo Therapeutics Inc. Cash and Cash Equivalents
Aptevo Therapeutics Inc. (APVO) had Cash and Cash Equivalents of $9.80 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $9.80M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $14.53M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $21.62M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $21.06M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $9.80M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $14.53M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $21.62M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $21.06M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $9.41M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $2.14M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $8.71M 10-K · filed 2026-03-26 |
| 2024-09-30 | $7.75M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $8.07M 10-Q · filed 2025-08-11 |
| 2024-03-31 | $10.25M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $16.90M 10-K · filed 2025-02-14 |
| 2023-09-30 | $19.11M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $21.01M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $25.33M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $22.64M 10-K · filed 2024-03-05 |
| 2022-09-30 | $22.15M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $29.43M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $34.99M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $45.04M 10-K · filed 2023-03-30 |
| 2021-09-30 | $52.12M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $60.39M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $57.52M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $39.98M 10-K · filed 2022-03-24 |
| 2020-09-30 | $24.94M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $7.60M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $12.26M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $12.45M 10-K · filed 2021-03-31 |
| 2019-09-30 | $17.68M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $20.96M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $37.01M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $30.64M 10-K · filed 2020-03-25 |
| 2018-09-30 | $28.45M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $7.23M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $11.83M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $7.09M 10-K · filed 2019-03-18 |
| 2017-09-30 | $75.83M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $22.27M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $14.01M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $9.68M 10-K · filed 2018-03-13 |
| 2016-09-30 | $10.89M 10-Q · filed 2017-11-13 |
| 2016-06-30 | $5.50M 10-Q · filed 2017-08-10 |
| 2016-03-31 | $3.07M 10-Q · filed 2017-05-12 |
| 2015-12-31 | $4.64M 10-K · filed 2018-03-13 |
| 2015-09-30 | $3.48M 10-Q · filed 2016-11-14 |
| 2015-06-30 | $4.05M 10-Q/A · filed 2016-09-22 |
| 2014-12-31 | $3.59M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |